Chiron Anticipates Fluvirin Shipments Will Begin In Late September/Early October
This article was originally published in The Pink Sheet Daily
Executive Summary
Company has several remaining regulatory hurdles before flu vaccine reaches the market.
You may also be interested in...
Chiron Minority Shareholder Will Oppose Novartis Takeover
Shareholder ValueAct Capital owns 5% of Chiron's shares and 9% of non-Novartis-owned shares.
Chiron Minority Shareholder Will Oppose Novartis Takeover
Shareholder ValueAct Capital owns 5% of Chiron's shares and 9% of non-Novartis-owned shares.
FDA Releases Three Lots Of Chiron's Fluvirin
Chiron received approval for its flu vaccine Sept. 14 after adequately addressing FDA's manufacturing concerns.